Lista de obras -

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection

artículo científico publicado en 2004

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda

artículo científico publicado en 2010

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

artículo científico publicado el 6 de junio de 2012

Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir

artículo científico publicado en 2014

CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types

artículo científico publicado en 2014

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load

artículo científico publicado en 2006

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

artículo científico publicado en 2009

Comprehensive analysis of unique cases with extraordinary control over HIV replication

artículo científico publicado en 2012

Cytotoxic Capacity of SIV-Specific CD8+ T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques ⬇️

artículo científico publicado el 28 de febrero de 2013

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

artículo científico publicado en 2007

Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

artículo científico publicado en 2009

Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function

scientific article published on 01 June 2003

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 ⬇️

artículo científico publicado el 1 de octubre de 2003

Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons

artículo científico publicado en 2006

Effect of antiretroviral therapy on HIV reservoirs in elite controllers

artículo científico publicado en 2013

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy

artículo científico publicado en 2012

Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings

artículo científico publicado en 2002

Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy

artículo científico publicado en 2009

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

artículo científico publicado en 2008

Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals

artículo científico publicado en 2003

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy

artículo científico publicado en 2003

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

artículo científico publicado en 2005

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

artículo científico publicado en 2002

Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

artículo científico publicado en 2008

IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation

artículo científico publicado en 2004

Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells

artículo científico publicado en 2007

Innate Immunity in HIV Infection

article

Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions

article

Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function

artículo científico publicado en 2003

Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients

article

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters

artículo científico publicado en 2003

Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells

artículo científico publicado en 2002

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

scientific article published on 08 December 2008

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy

artículo científico publicado en 2008

Perturbations in B cell responsiveness to CD4 + T cell help in HIV-infected individuals ⬇️

artículo científico publicado el 13 de mayo de 2003

Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection ⬇️

artículo científico publicado el 14 de diciembre de 2001

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

artículo científico publicado en 2010

Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy ⬇️

artículo científico publicado el 1 de julio de 2011

Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals

artículo científico publicado en 2004

Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy

artículo científico publicado en 2002

The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences

artículo científico publicado en 2003

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles

artículo científico publicado en 2011

Lista de obras de

A proof-of-concept study of short-cycle intermittent antiretroviral therapy with a once-daily regimen of didanosine, lamivudine, and efavirenz for the treatment of chronic HIV infection

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda

Antibody-Dependent Cellular Cytotoxicity against Primary HIV-Infected CD4+T Cells Is Directly Associated with the Magnitude of Surface IgG Binding ⬇️

Broadly neutralizing antibodies suppress HIV in the persistent viral reservoir

CD8(+) T-cell Cytotoxic Capacity Associated with Human Immunodeficiency Virus-1 Control Can Be Mediated through Various Epitopes and Human Leukocyte Antigen Types

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load

Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency, Immunodominance, Phenotype, and Interleukin-2 Responsiveness

Comprehensive analysis of unique cases with extraordinary control over HIV replication

Cytotoxic Capacity of SIV-Specific CD8+ T Cells against Primary Autologous Targets Correlates with Immune Control in SIV-Infected Rhesus Macaques ⬇️

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus

Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy.

Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function

Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 ⬇️

Diminished production of monocyte proinflammatory cytokines during human immunodeficiency virus viremia is mediated by type I interferons

Effect of antiretroviral therapy on HIV reservoirs in elite controllers

Effect of histone deacetylase inhibitors on HIV production in latently infected, resting CD4(+) T cells from infected individuals receiving effective antiretroviral therapy

Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings

Evaluation of the pathogenesis of decreasing CD4(+) T cell counts in human immunodeficiency virus type 1-infected patients receiving successfully suppressive antiretroviral therapy

Frequency and phenotype of human immunodeficiency virus envelope-specific B cells from patients with broadly cross-neutralizing antibodies

Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals

Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy

HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir

HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors

Human immunodeficiency virus viremia induces plasmacytoid dendritic cell activation in vivo and diminished alpha interferon production in vitro.

IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation

Impact of HIV on cell survival and antiviral activity of plasmacytoid dendritic cells

Innate Immunity in HIV Infection

Innate immune dysfunction in HIV infection: effect of HIV envelope-NK cell interactions

Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function

Interruption of antiretroviral therapy blunts but does not abrogate CD4 T-cell responses to interleukin-2 administration in HIV infected patients

Long-cycle structured intermittent versus continuous highly active antiretroviral therapy for the treatment of chronic infection with human immunodeficiency virus: effects on drug toxicity and on immunologic and virologic parameters

Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells

Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control

Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy

Perturbations in B cell responsiveness to CD4 + T cell help in HIV-infected individuals ⬇️

Pilot Study of the Effects of Intermittent Interleukin‐2 on Human Immunodeficiency Virus (HIV)–Specific Immune Responses in Patients Treated during Recently Acquired HIV Infection ⬇️

Rebound of plasma viremia following cessation of antiretroviral therapy despite profoundly low levels of HIV reservoir: implications for eradication

Relationship Between Residual Plasma Viremia and the Size of HIV Proviral DNA Reservoirs in Infected Individuals Receiving Effective Antiretroviral Therapy ⬇️

Relationship between the frequency of HIV-specific CD8+ T cells and the level of CD38+CD8+ T cells in untreated HIV-infected individuals

Relationship between the size of the human immunodeficiency virus type 1 (HIV-1) reservoir in peripheral blood CD4+ T cells and CD4+:CD8+ T cell ratios in aviremic HIV-1-infected individuals receiving long-term highly active antiretroviral therapy

The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences

Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles